Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furong Liu

Showing results (191-200 of 193) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 193 results.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers explorationYunxin Lu, Yin Jin, Furong Liu, et al.
Science Advances|November 25, 2015
The rice immune receptor XA21 recognizes a tyrosine-sulfated protein from a Gram-negative bacteriumRory N Pruitt, Benjamin Schwessinger, Anna Joe, et al.
Imeta|December 31, 2025
<i>iMeta</i> Conference 2025: Creating high-impact international journalsZhihao Zhu, Lin Zhang, Xiaofang Yao, et al.
Pageof 20

Showing results (191-200 of 193) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 193 results.
Cancer Immunology, Immunotherapy : CII|September 5, 2024
Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers explorationYunxin Lu, Yin Jin, Furong Liu, et al.
Science Advances|November 25, 2015
The rice immune receptor XA21 recognizes a tyrosine-sulfated protein from a Gram-negative bacteriumRory N Pruitt, Benjamin Schwessinger, Anna Joe, et al.
Imeta|December 31, 2025
<i>iMeta</i> Conference 2025: Creating high-impact international journalsZhihao Zhu, Lin Zhang, Xiaofang Yao, et al.
Pageof 20